Clough Capital Partners L P Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Clough Capital Partners L P

$924 Million
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$67.31 - $79.26 $2.84 Million - $3.34 Million	42,200 New	42,200 $3.28 Million
Q2 2022 Aug 16, 2022	SELL	$72.65 - $83.96 $2.52 Million - $2.91 Million	-34,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$73.73 - $80.41 $2.59 Million - $2.82 Million	-35,100 Reduced 50.29%	34,700 $2.77 Million
Q4 2021 Feb 14, 2022	SELL	$71.36 - $77.51 $1.66 Million - $1.81 Million	-23,300 Reduced 25.03%	69,800 $5.37 Million
Q3 2021 Nov 15, 2021	BUY	$72.19 - $77.22 $6.72 Million - $7.19 Million	93,100 New	93,100 $6.78 Million
Q1 2021 May 17, 2021	SELL	$66.06 - $71.06 $21.8 Million - $23.5 Million	-330,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$58.91 - $66.91 $19.5 Million - $22.1 Million	330,400 New	330,400 $22 Million

Others Institutions Holding PPH

# of Institutions

146

Shares Held

5.83M

Call Options Held

12.6K

Put Options Held

7.3K

Goldman Sachs Group Inc New York, NY

2.1M
Shares

$182 Million
0.03% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

319K
Shares

$27.6 Million
0.07% of portfolio
Avalon Trust CO Santa Fe, NM

283K
Shares

$24.5 Million
1.99% of portfolio
Mirae Asset Global Investments Co., Ltd.

248K
Shares

$21.5 Million
0.1% of portfolio
Thrivent Financial For Lutherans Minneapolis, MN

235K
Shares

$20.3 Million
0.04% of portfolio

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.